130 related articles for article (PubMed ID: 33646044)
1. Bipolar Distribution of Minimum Inhibitory Concentration of Q203 Across Mycobacterial Species.
Wang J; Jing W; Shi J; Huo F; Shang Y; Wang F; Chu N; Pang Y
Microb Drug Resist; 2021 Aug; 27(8):1013-1017. PubMed ID: 33646044
[TBL] [Abstract][Full Text] [Related]
2.
Dong W; Li S; Wen S; Jing W; Shi J; Ma Y; Huo F; Gao F; Pang Y; Lu J
Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31791947
[TBL] [Abstract][Full Text] [Related]
3. Telacebec (Q203): Is there a novel effective and safe anti-tuberculosis drug on the horizon?
Malík I; Čižmárik J; Kováč G; Pecháčová M; Hudecova L
Ceska Slov Farm; 2021; 70(5):164-171. PubMed ID: 35114793
[TBL] [Abstract][Full Text] [Related]
4. Naturally-Occurring Polymorphisms in QcrB Are Responsible for Resistance to Telacebec in
Sorayah R; Manimekalai MSS; Shin SJ; Koh WJ; Grüber G; Pethe K
ACS Infect Dis; 2019 Dec; 5(12):2055-2060. PubMed ID: 31599569
[No Abstract] [Full Text] [Related]
5. Telacebec (Q203): Is there a novel effective and safe anti-tuberculosis drug on the horizon?
Malík I; Čižmárik J; Kováč G; Pecháčová M; Hudecova L
Ceska Slov Farm; 2021; 70(5):164–171. PubMed ID: 34875838
[TBL] [Abstract][Full Text] [Related]
6.
Litvinov V; Makarova M; Kudlay D; Nikolenko N; Mikhailova J
J Med Microbiol; 2021 Oct; 70(10):. PubMed ID: 34668850
[No Abstract] [Full Text] [Related]
7. Efflux Attenuates the Antibacterial Activity of Q203 in Mycobacterium tuberculosis.
Jang J; Kim R; Woo M; Jeong J; Park DE; Kim G; Delorme V
Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28416541
[TBL] [Abstract][Full Text] [Related]
8. Comparison of
Zong Z; Jing W; Shi J; Wen S; Zhang T; Huo F; Shang Y; Liang Q; Huang H; Pang Y
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29844043
[TBL] [Abstract][Full Text] [Related]
9.
Pang Y; Zheng H; Tan Y; Song Y; Zhao Y
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242674
[TBL] [Abstract][Full Text] [Related]
10. Identification of Mycobacterium species following growth detection with the BACTEC MGIT 960 system by DNA line probe assay.
Ng KP; Rukumani DV; Chong J; Kaur H
Int J Mycobacteriol; 2014 Jun; 3(2):82-7. PubMed ID: 26786328
[TBL] [Abstract][Full Text] [Related]
11. Differences in drug susceptibility pattern between Mycobacterium avium and Mycobacterium intracellulare isolated in respiratory specimens.
Cho EH; Huh HJ; Song DJ; Moon SM; Lee SH; Shin SY; Kim CK; Ki CS; Koh WJ; Lee NY
J Infect Chemother; 2018 Apr; 24(4):315-318. PubMed ID: 29223615
[TBL] [Abstract][Full Text] [Related]
12. Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis.
Pethe K; Bifani P; Jang J; Kang S; Park S; Ahn S; Jiricek J; Jung J; Jeon HK; Cechetto J; Christophe T; Lee H; Kempf M; Jackson M; Lenaerts AJ; Pham H; Jones V; Seo MJ; Kim YM; Seo M; Seo JJ; Park D; Ko Y; Choi I; Kim R; Kim SY; Lim S; Yim SA; Nam J; Kang H; Kwon H; Oh CT; Cho Y; Jang Y; Kim J; Chua A; Tan BH; Nanjundappa MB; Rao SP; Barnes WS; Wintjens R; Walker JR; Alonso S; Lee S; Kim J; Oh S; Oh T; Nehrbass U; Han SJ; No Z; Lee J; Brodin P; Cho SN; Nam K; Kim J
Nat Med; 2013 Sep; 19(9):1157-60. PubMed ID: 23913123
[TBL] [Abstract][Full Text] [Related]
13. Nationwide analysis of Mycobacterium chimaera and Mycobacterium intracellulare isolates: Frequency, clinical importance, and molecular and phenotypic resistance profiles.
Truden S; Žolnir-Dovč M; Sodja E; Starčič Erjavec M
Infect Genet Evol; 2020 Aug; 82():104311. PubMed ID: 32247868
[TBL] [Abstract][Full Text] [Related]
14. Real time PCR for the rapid identification and drug susceptibility of Mycobacteria present in Bronchial washings.
Keerthirathne TP; Magana-Arachchi DN; Madegedara D; Sooriyapathirana SS
BMC Infect Dis; 2016 Oct; 16(1):607. PubMed ID: 27782812
[TBL] [Abstract][Full Text] [Related]
15. Shortening Buruli Ulcer Treatment with Combination Therapy Targeting the Respiratory Chain and Exploiting Mycobacterium ulcerans Gene Decay.
Converse PJ; Almeida DV; Tyagi S; Xu J; Nuermberger EL
Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31036687
[TBL] [Abstract][Full Text] [Related]
16. The anti-mycobacterial activity of the cytochrome bcc inhibitor Q203 can be enhanced by small-molecule inhibition of cytochrome bd.
Lu P; Asseri AH; Kremer M; Maaskant J; Ummels R; Lill H; Bald D
Sci Rep; 2018 Feb; 8(1):2625. PubMed ID: 29422632
[TBL] [Abstract][Full Text] [Related]
17. In Vitro Anti-mycobacterial Activity of Three Medicinal Plants of Lamiaceae Family.
Kazemian H; Heidari H; Yamchi JK; Zandi H; Taji A; Yazdani F; Hamzehloo G; Ghanavati R; Rahdar HA; Feizabadi MM
Recent Pat Antiinfect Drug Discov; 2018; 13(3):240-245. PubMed ID: 29952265
[TBL] [Abstract][Full Text] [Related]
18. Combating highly resistant emerging pathogen Mycobacterium abscessus and Mycobacterium tuberculosis with novel salicylanilide esters and carbamates.
Baranyai Z; Krátký M; Vinšová J; Szabó N; Senoner Z; Horváti K; Stolaříková J; Dávid S; Bősze S
Eur J Med Chem; 2015 Aug; 101():692-704. PubMed ID: 26210507
[TBL] [Abstract][Full Text] [Related]
19.
Luo J; Yu X; Jiang G; Fu Y; Huo F; Ma Y; Wang F; Shang Y; Liang Q; Xue Y; Huang H
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29760127
[TBL] [Abstract][Full Text] [Related]
20. Difference in drug susceptibility distribution and clinical characteristics between
Wang W; Yang J; Wu X; Wan B; Wang H; Yu F; Guo Y
J Med Microbiol; 2021 May; 70(5):. PubMed ID: 33999797
[No Abstract] [Full Text] [Related]
[Next] [New Search]